[
  {
    "ts": null,
    "headline": "BFLY's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Climbs",
    "summary": "Butterfly Network's Q3 loss widens but revenues top estimates, lifting shares as new AI tools and chip advances drive optimism.",
    "url": "https://finnhub.io/api/news?id=a0bdd13913f922b004918b75df532d198991e1bf01125c8e33d96ceac56edcb2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761923100,
      "headline": "BFLY's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Climbs",
      "id": 137279194,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Butterfly Network's Q3 loss widens but revenues top estimates, lifting shares as new AI tools and chip advances drive optimism.",
      "url": "https://finnhub.io/api/news?id=a0bdd13913f922b004918b75df532d198991e1bf01125c8e33d96ceac56edcb2"
    }
  },
  {
    "ts": null,
    "headline": "Demographic Megatrend: Stocks Poised to Benefit From Global Aging",
    "summary": "Global aging is reshaping healthcare demand. Discover how AbbVie, Amgen, Boston Scientific and Edwards are positioned to gain from this powerful megatrend.",
    "url": "https://finnhub.io/api/news?id=2b367ca0fca3393f3bdea85762cdbcf46c42c9eb9ffbc799caabac0ef05ed58a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761922260,
      "headline": "Demographic Megatrend: Stocks Poised to Benefit From Global Aging",
      "id": 137279095,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Global aging is reshaping healthcare demand. Discover how AbbVie, Amgen, Boston Scientific and Edwards are positioned to gain from this powerful megatrend.",
      "url": "https://finnhub.io/api/news?id=2b367ca0fca3393f3bdea85762cdbcf46c42c9eb9ffbc799caabac0ef05ed58a"
    }
  },
  {
    "ts": null,
    "headline": "Is Boston Scientific (BSX) Becoming the Leading MedTech Growth Story?",
    "summary": "Boston Scientific Corp. (NYSE:BSX) is one of the best stocks to buy according to Citadel LLC. On October 22, Josh Jennings, an analyst at TD Cowen, reiterated his $115 price target and Buy rating on the stock after the company reported strong Q3 2025 results. Jennings said the company’s 15.3% organic growth was the highlight of […]",
    "url": "https://finnhub.io/api/news?id=92d5727dff59684fdb2fa1015bba567200cc84efb02d578ee72ebc787ce5efb2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761922240,
      "headline": "Is Boston Scientific (BSX) Becoming the Leading MedTech Growth Story?",
      "id": 137279196,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corp. (NYSE:BSX) is one of the best stocks to buy according to Citadel LLC. On October 22, Josh Jennings, an analyst at TD Cowen, reiterated his $115 price target and Buy rating on the stock after the company reported strong Q3 2025 results. Jennings said the company’s 15.3% organic growth was the highlight of […]",
      "url": "https://finnhub.io/api/news?id=92d5727dff59684fdb2fa1015bba567200cc84efb02d578ee72ebc787ce5efb2"
    }
  },
  {
    "ts": null,
    "headline": "Do Wall Street Analysts Like Boston Scientific Stock?",
    "summary": "As Boston Scientific has outpaced the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=8f9cfe4cc2818c76644f5729bcb17de11192446794e43eb306790d7a23182a5c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761921044,
      "headline": "Do Wall Street Analysts Like Boston Scientific Stock?",
      "id": 137279197,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "As Boston Scientific has outpaced the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=8f9cfe4cc2818c76644f5729bcb17de11192446794e43eb306790d7a23182a5c"
    }
  },
  {
    "ts": null,
    "headline": "SYK Stock Falls Despite Q3 Earnings & Sales Beat, '25 View Up",
    "summary": "Stryker's Q3 results top estimates with double-digit sales and profit growth, but shares slip as investors weigh tariff pressures despite an upbeat 2025 outlook.",
    "url": "https://finnhub.io/api/news?id=12f99e6297268fea11cc7f545dfb00552810c82ea0661e073dcb0c5f80dda3e2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761920280,
      "headline": "SYK Stock Falls Despite Q3 Earnings & Sales Beat, '25 View Up",
      "id": 137279198,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Stryker's Q3 results top estimates with double-digit sales and profit growth, but shares slip as investors weigh tariff pressures despite an upbeat 2025 outlook.",
      "url": "https://finnhub.io/api/news?id=12f99e6297268fea11cc7f545dfb00552810c82ea0661e073dcb0c5f80dda3e2"
    }
  },
  {
    "ts": null,
    "headline": "Resmed Stock Up on Q1 Earnings & Revenue Beat, Margins Expand",
    "summary": "RMD's Q1 earnings and revenues top estimates as solid device and mask sales lift margins and boost investor confidence.",
    "url": "https://finnhub.io/api/news?id=02c674240fc6ad2d3dabfbec9c78a2228b595975b1541b7060ab8eeebac4b479",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761913320,
      "headline": "Resmed Stock Up on Q1 Earnings & Revenue Beat, Margins Expand",
      "id": 137279199,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "RMD's Q1 earnings and revenues top estimates as solid device and mask sales lift margins and boost investor confidence.",
      "url": "https://finnhub.io/api/news?id=02c674240fc6ad2d3dabfbec9c78a2228b595975b1541b7060ab8eeebac4b479"
    }
  },
  {
    "ts": null,
    "headline": "2 Large-Cap Stocks Worth Investigating and 1 That Underwhelm",
    "summary": "Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.",
    "url": "https://finnhub.io/api/news?id=3ba8af94d926bb8b2c6af6922baa2c63c974f944ed84de9119979fc7b5717e0c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761885982,
      "headline": "2 Large-Cap Stocks Worth Investigating and 1 That Underwhelm",
      "id": 137275092,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.",
      "url": "https://finnhub.io/api/news?id=3ba8af94d926bb8b2c6af6922baa2c63c974f944ed84de9119979fc7b5717e0c"
    }
  }
]